A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use...
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains,...
Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed....
A new review highlights significant gaps in the evidence for medical cannabis, but other researchers say it may not present a balanced picture.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new...
The study found that 88% of participating officers knew little or nothing about the regulations before taking part in the training.
The authors say the guidance aims to address "clear gaps" in prescriber training and education.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively...
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the...
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line...
